Individual genomes and personalized medicine: Life diversity and complexity

Personalized Medicine

Volumn 7, Issue 4, 2010, Pages 347-350

  Katsios, Christos ^a   Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; CANCER GENETICS; EDITORIAL; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL PRACTICE; PHARMACOGENOMICS; PRIORITY JOURNAL;

EID: 77956250186     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.10.30     Document Type: Editorial

References (34)

1. Lander ES, Linton LM, Birren B et al.; International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
2. Venter JC, Adams MD, Myers EW et al.: The sequence of the human genome. Science 291, 1304-1351 (2001).
3. Roederer MW: Cytochrome P450 enzymes and genotype-guided drug therapy. Curr. Opin. Mol. Ther. 11(6), 632-640 (2009).
4. The human genome at ten. Nature 464(7289), 649-650 (2010).
5. Check Hayden E: Human genome at ten: life is complicated. Nature 464(7289), 664-667 (2010).
6. Human genome at ten: the sequence explosion. Nature 464(7289), 670-671 (2010).
7. Collins F: Has the revolution arrived? Nature 464(7289), 674-675 (2010).
8. Venter JC: Multiple personal genomes await. Nature 464(7289), 676-677 (2010).
9. Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature 458(7239), 719-724 (2009).
10. Pleasance ED, Stephens PJ, OMeara S et al.: A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463(7278), 184-190 (2010).
11. Pleasance ED, Cheetham RK, Stephens PJ et al.: A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463(7278), 191-196 (2010).
12. Shah SP, Morin RD, Khattra J et al.: Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461(7265), 809-813 (2009).
13. Stephens PJ, McBride DJ, Lin ML et al.: Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462(7276), 1005-1010 (2009).
14. Beroukhim R, Mermel CH, Porter D et al.: The landscape of somatic copy-number alteration across human cancers. Nature 463(7283), 899-905 (2010).
15. Heppner GH: Tumor heterogeneity. Cancer Res. 44(6), 2259-2265 (1984).
16. He Y, Wu J, Dressman DC, Iacobuzio- Donahue C et al.: Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464(7288), 610-614 (2010).
17. Jones S, Zhang X, Parsons DW: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897), 1801-1806 (2008).
18. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100, 57-70 (2000).
19. Roukos DH: Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3), 283-287 (2010).
20. Schadt EE: Molecular networks as sensors and drivers of common human diseases. Nature 461(7261), 218-223 (2009).
21. Rockman MV: Reverse engineering the genotype-phenotype map with natural genetic variation. Nature 456, 738-744 (2008).
22. Goldstein DB: 2020 visions: personalized medicine. Nature 463(7277), 26-32 (2010).
23. Kathiresan S, Melander O, Anevski D et al.: Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358(12), 1240-1249 (2008).
24. Wacholder S, Hartge P, Prentice R et al.: Performance of common genetic variants in breast-cancer risk models. N. Engl. J. Med. 362(11), 986-993 (2010).
25. Roukos DH: Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev. Mol. Diagn. 10(3), 247-250 (2010).
26. Weinberg R: Point: hypotheses first. Nature 464(7289), 678 (2010).
27. Roukos DH, Ziogas D: From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev. Anticancer Ther. 10(2), 123-128 (2010).
28. Roukos DH: Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev. Mol. Diagn. 10(1), 33-48 (2010).
29. Ziogas D, Roukos DH: Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann. Surg. Oncol. 16(7), 1771-1782 (2009).
30. Roukos DH: Personalized cancer diagnostics and therapeutics. Expert Rev. Mol. Diagn. 9(3), 227-229 (2009).
31. Roukos DH: Radiation therapy for breast cancer. N. Engl. J. Med. 360(13), 1362; author reply 1363 (2009).
32. Roukos DH: Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann. Surg. Oncol. 17, 14-17 (2010).
33. Roukos DH: Twenty-One-Gene Assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J. Clin. Oncol. 27(8), 1337-1338 (2009).
34. Roukos DH: Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann. Surg. Oncol. 16(3), 772-773 (2009).